90 related articles for article (PubMed ID: 27668530)
1. Bone Metabolism of the Patient with a Malignant Melanoma during the Entry Examination and the Check-up of Whole-body Bone Scintigraphy.
Weissensteiner J; Babušíková E
Prague Med Rep; 2016; 117(2-3):129-134. PubMed ID: 27668530
[TBL] [Abstract][Full Text] [Related]
2. [The possibility of the serum concentration of osteocalcin determination in lung cancer patients with suspected bone metastases].
Weissensteiner J; Babušíková E
Klin Onkol; 2015; 28(1):51-6. PubMed ID: 25692755
[TBL] [Abstract][Full Text] [Related]
3. The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients.
Weissensteiner J; Babusikova E
Neoplasma; 2019 Nov; 66(6):1024-1030. PubMed ID: 31307200
[TBL] [Abstract][Full Text] [Related]
4. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies using measurement of N-telopeptides of type 1 collagen (NTx) in patients with bone metastasis--comparison with bone scintigraphy and other metabolic bone markers].
Yamamoto I; Morita R; Konishi J; Shigeno C; Ikekubo K; Hino M; Sone T; Fujimoto R
Kaku Igaku; 1995 May; 32(5):501-10. PubMed ID: 7596071
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
7. [Procollagen-I, collagen telopeptide I, CEA, CA 15-3 as compared to bone scintigraphy in patients with breast cancer].
Zissimopoulos A; Petrakis G; Stellos K; Baziotis N
Hell J Nucl Med; 2006; 9(1):60-4. PubMed ID: 16617400
[TBL] [Abstract][Full Text] [Related]
8. Beta-CTX and ICTP act as indicators of skeletal metastasis status in male patients with non-small cell lung cancer.
Kong QQ; Sun TW; Dou QY; Li F; Tang Q; Pei FX; Tu CQ; Chen ZQ
Int J Biol Markers; 2007; 22(3):214-20. PubMed ID: 17922466
[TBL] [Abstract][Full Text] [Related]
9. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
Nicolini A; Ferrari P; Sagripanti A; Carpi A
Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
[TBL] [Abstract][Full Text] [Related]
10. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
Zulauf N; Brüggmann D; Groneberg D; Oremek GM
Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
[TBL] [Abstract][Full Text] [Related]
11. The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer.
Bayrak SB; Ceylan E; Serter M; Karadağ F; Demir E; Çildağ O
Int J Clin Oncol; 2012 Apr; 17(2):112-8. PubMed ID: 21691728
[TBL] [Abstract][Full Text] [Related]
12. Serological bone markers and joint damage in early polyarthritis.
Jansen LM; van der Horst-Bruinsma I; Lems WF; van Schaardenburg D; van de Stadt R; de Koning M; Dijkmans BA
J Rheumatol; 2004 Aug; 31(8):1491-6. PubMed ID: 15290726
[TBL] [Abstract][Full Text] [Related]
13. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
[TBL] [Abstract][Full Text] [Related]
14. [Bone scintigraphy for diagnosis of bone metastasis in patients with prostatic cancer].
Nakashima J
Nihon Rinsho; 2002 Dec; 60 Suppl 11():135-9. PubMed ID: 12599559
[No Abstract] [Full Text] [Related]
15. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
[TBL] [Abstract][Full Text] [Related]
16. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
17. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute citrate load on markers of bone metabolism in healthy volunteers.
Chen Y; Bieglmayer C; Höcker P; Dettke M
Vox Sang; 2009 Nov; 97(4):324-9. PubMed ID: 19508702
[TBL] [Abstract][Full Text] [Related]
19. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]